According to ARS, the FDA regulators decided at the time that more data was needed to evaluate the safety of repeated doses of the nasal spray before it could be approved. "Neffy is epinephrine ...

On Friday, the FDA announced the approval of neffy, an epinephrine nasal spray by ARS Pharmaceuticals ... associate director of the Division of Pulmonology, Allergy and Critical Care in the ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first ... associate director of the division of pulmonology, allergy and critical care at the FDA's Center ...

Emergency crews were called to the scene after a semi crashed into a building in West Chicago on Wednesday afternoon. A federal judge is expected to rule on a request to stop President Trump's ...

Previously called STS101, the company said Wednesday that the drug’s brand name is Atzumi and is indicated for acute migraine ...

Colorado House Republicans are asking the United States Attorney General’s Office to review the new state law on the purchase of semiautomatic firearms.

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters ...

A report from the Department of Homeland Security about a man whose case has received national attention after he was deported from Maryland to El Salvador alleged that he was pulled over by the ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...